Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as “expects”, “will”, “anticipates”, and “estimates”; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief “snapshot” of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled “Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

State-of-the-Art Hemp Cigarette Manufacturer Headquartered near Winston-Salem, North Carolina

AUSTIN, May 01, 2023 (GLOBE NEWSWIRE) — Indoor Harvest Corp. (OTCPK: INQD) (the “Company”) a company focused on sustainable-hemp and wellness related products, is pleased to announce the completion of the acquisition of Opportunity Development Group, LLC, and its subsidiary 369Hemp, Inc. (collectively referred to as “369Hemp®”), for a combination of cash and common stock.

Born from a passion for craftsmanship and quality, 369Hemp®’s mission is to pioneer the creation, production, and distribution of hemp cigarettes. Utilizing time-tested techniques from master hemp growers and cigarette manufacturers, 369Hemp® creates products of the highest caliber from a 30,000 sq ft facility in North Carolina. 369Hemp® current brands include 369Hemp and white-labeled hemp cigarettes. The distribution model consists of online direct to consumer, in-store retail, and wholesale markets. Hemp Industry Daily estimates the smokeable hemp market to reach $300-400M by 2025.

“I was fortunate enough to meet Travis Priddy through mutual relationships several years ago. We immediately connected on common strategies and opportunities. I am thrilled to now bring the innovation of these new brands to the smokeable hemp industry. By adding an established hemp cigarette manufacturing platform to Indoor Harvest’s business, we are confident we will immediately reap the rewards from 369Hemp®’s team and technology to market, manufacture, and distribute hemp cigarettes globally,” said Leslie Bocskor, CEO and Chairman of INQD. “We believe there is vast opportunity in this space and by capturing just a small percentage of the North American market we will be a strong contender in smokeable hemp. Travis is truly a shining star, and we are lucky to have him and his team as a part of Indoor Harvest.”

“I have been dreaming of working with Leslie since we met in 2018,” said Travis Priddy, CEO and founder of 369Hemp®. “We have created an authentic, true quality alternative cigarette to what most smokers are currently accustomed to with manufacturing efficiency at speeds to scale. We designed a system to run premium biomass and use the best grade material which is hemp flower that is USDA compliant farm regulated hemp, registered, and certified by the state of North Carolina. Indoor Harvest will help us lay the foundation to create the Gold Standard to deliver on the promise of a truly healthy alterative for smokers.”

Priddy is a seasoned cigarette industry sales executive and entrepreneur, with more than 20 years’ experience. He has previously worked for Altria and Philip Morris International in both domestic and international markets. Priddy’s prior roles focused on national sales and merchandising, new business development, and new product launch strategies in a variety of countries. Priddy received a Bachelor of Arts from the University of North Carolina at Chapel Hill. As part of the acquisition, Priddy will be retained under a new employment agreement as President of 369Hemp®.

About 369Hemp®
369Hemp® was founded on the ideals of quality, consistency, and sophistication elevating the hemp industry while paying homage to the “Art of the Smoke”. We are pioneering the creation, production and distribution of hemp cigarettes made from the finest American hemp. We are building the highest capacity and most technologically sophisticated hemp cigarette manufacturing facility in the United States.

About Indoor Harvest:
Indoor Harvest Corp. (OTCPK: INQD) is a company of sustainable-hemp and wellness related products which incorporates the development of proprietary technology, mergers, acquisitions, strategic partnerships, and joint ventures as part of a broad integration strategy. INQD cultivates partnerships within related industries, providing an opportunity to be part of a more significant play, sharing intellectual capital, technology, access to new capital markets, and liquidity for owners.

Forward Looking Statements:
This document contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect our views about future events and financial performance and are generally not historical facts. Words such as “expect,” “feel,” “believe,” “will,” “may,” “should,” “anticipate,” “intend,” “estimate,” “project,” “forecast,” “plan” and similar expressions are intended to identify forward-looking statements. These statements include but are not limited to financial projections and estimates and their underlying assumptions; statements regarding plans, objectives, and expectations with respect to future operations, products, and services; and statements regarding future performance. Such statements are subject to certain risks and uncertainties, many of which are difficult to predict and generally beyond our control, that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking statements. You are cautioned not to place undue reliance on these forward- looking statements that speak only as of the date hereof. You are also urged to carefully review and consider the various risks and other disclosures discussed in our reports filed with the U.S. Securities and Exchange Commission from time to time, which attempt to advise interested parties of the factors that affect our business. Except to the extent otherwise required by federal securities laws, we do not undertake any obligation to republish revised forward-looking statements to reflect events or circumstances after the date hereof. Risks include but are not limited to general risks associated with mergers, acquisitions, joint ventures, and strategic alliances; lack of sufficient capital, changes in U.S. hemp and related laws; possible impairment of assets, COVID and more.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Vancouver, British Columbia–(Newsfile Corp. – March 6, 2023) – CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (the “Company“) announced today that it completed the previously announced non-brokered private placement financing pursuant to the listed issuer financing exemption under Part 5A of NI 45-106 (the “Financing“) on March 3, 2023. Pursuant to the Financing, the Corporation issued an aggregate of $4,999,999.80 of units of the Company (the “Units“) at an issue price of $0.30 per Unit.

Each Unit is comprised of one common share (a “Common Share“) and one common share purchase ‎warrant of the Company (a “Warrant“). Each Warrant is exercisable to acquire one common share of the Company (a “Warrant Share“) at an exercise price of $0.50 per Warrant Share for a period of three years following the date of issue, subject to a redemption timing adjustments in certain events. If, at any time following the Closing Date, the daily volume weighted average trading price of the Common Shares on the Canadian Securities Exchange (the “CSE“) is greater than $0.70 per Common Share for a period of 5 consecutive trading days (the “Triggering Event“), the Company shall have the right to accelerate the expiry date of the Warrants to a date not less than 30 days after the later of: (i) the date that notice of such acceleration is provided to the Warrant holders; and (ii) the date of issuance of a press release disclosing the occurrence of the Triggering Event.

Certain founding shareholders and insiders of the Company participated in the Financing, and subscribed for a total of 9,319,966 Units, which is a “related party transaction” within the meaning of Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101“). The issuances to the insiders are exempt from the valuation and the minority shareholder approval requirements of MI 61-101. The Company did not file a material change report more than 21 days before the expected closing of the Financing as the details of the Financing and the participation therein by related parties were not settled until shortly prior to closing and the Company wished to close on an expedited basis for sound business reasons.

The net proceeds of the Financing will be used for general working capital purposes. The Company paid a finder’s fee in connection with the sale of certain of the Units to subscribers introduced to the Company by finders.

Early Warning Reporting Disclosure

In connection with the Financing, the Company issued 9,149,966 Units to certain entities controlled by Paul Meehan (collectively “Meehan“) at a price of $0.30 per Unit, for aggregate gross proceeds of $2,744,989.80.

As of March 1, 2023, Meehan had control over 15,598,883 Common Shares, representing 15.9% of the issued and outstanding Common Shares, and 1,540,000 Common Share-purchase warrants. Assuming the exercise of the Common Share-purchase warrants, Meehan would have control or direction over 17,138,883 Common Shares, representing 17.2% of the issued and outstanding Common Shares as of March 1, 2023.

Immediately after the closing of the Financing, Meehan had control of 24,748,849 Common Shares, representing 21.6% of the issued and outstanding Common Shares, and 10,689,966 Common Share-purchase warrants. Assuming the exercise of the Warrants, Meehan would have control or direction over 35,438,815 Common Shares, representing 31.0% of the issued and outstanding Common Shares.

Meehan’s acquisition of the Units was made for investment purposes. Subject to applicable laws, Meehan may acquire additional securities of the Company or may dispose of any or all of its holdings of Common Shares, from time to time through, among other things, transactions on the open market or in private transactions or otherwise, on such terms and at such times as Meehan may deem advisable depending upon an ongoing evaluation of the Common Shares, the Company, prevailing market conditions, the availability of Common Shares at prices that would make the purchase or sale of Common Shares desirable, other investment opportunities, liquidity requirements of the Acquiror, respectively, and/or other considerations and in such manner as it deems appropriate, subject to applicable laws.

A copy of the early warning report filed by Meehan in connection with the above will be filed on SEDAR and made available under the Company’s issuer profile on SEDAR at www.sedar.com.

For further information, please contact Yuki Sugiyama at 604-733-1514.

About CENTR Brands Corp.

CENTR Brands Corp. is one of North America’s leading functional wellness beverage companies. The Company develops and markets non-alcoholic, functional beverages and powders for the global market. The Company produces CENTR and CENTR Sugar Free, both sparkling, low calorie CBD beverages; CENTR Instant, a family of on-the-go, adaptogen-based CBD powders; and CENTR Enhanced, a refreshing, ZERO calorie, non-CBD, nootropic and adaptogen sparkling water incorporating a variety of science-backed ingredients.

For more information on CENTR Brands visit www.findyourcentr.com or contact us at media@findyourcentr.com. Be sure to follow us on social media @findyourcentr and @drinkcentr.

Consumers that do not yet have a local CENTR Brands retailer can visit our online store at: www.findyourcentr.com.

On behalf of the Board,

CENTR BRANDS CORP.
“Arjan Chima”
Arjan Chima, Chief Executive Officer

Forward-Looking Information
This press release may contain “Forward-Looking Statements” within the meaning of applicable Canadian securities laws. Forward-looking statements are not comprised of historical facts. Forward-looking statements include estimates ‎and statements that describe the Company’s future plans, objectives or goals, including words to the effect that the ‎Company or management expects a stated condition or result to occur. Forward-looking statements may be ‎identified by such terms as “believes”, “anticipates”, “expects”, “estimates”, “may”, “could”, “would”, “will”, or ‎‎”plan”. Since forward-looking statements are based on assumptions and address future events and conditions, by ‎their very nature they involve inherent risks and uncertainties. Although these statements are based on information ‎currently available to the Company, the Company provides no assurance that actual results will meet management’s ‎expectations. Risks, uncertainties and other factors involved with forward-looking information could cause actual ‎events, results, performance, prospects and opportunities to differ materially from those expressed or implied by ‎such forward-looking information‎. Forward looking information in this news release includes, but is not limited to, the Company’s intentions regarding ‎its objectives, goals or future plans and statements, including with respect to the intended use of the net proceeds of the Financing and the proposed sale of additional Units of the Company on similar terms as the Financing.‎ Many factors, both known and unknown, could cause results, performance or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements. The Company does not intend, and does not assume any obligation, to update these forward-looking statements or information to reflect changes in assumptions or changes in circumstances or any other events affecting such statements and information other than as required by applicable laws, rules and regulations.

The CSE has not reviewed, approved, or disapproved the contents of this press release.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

<!– (adsbygoogle = window.adsbygoogle || []).push({ google_ad_client: “ca-pub-5707738102681835”, enable_page_level_ads: true }); –>

<!– Click –>

New Clinical Facility in London, Ontario Accelerates Research and Innovation

VANCOUVER, British Columbia, September 26, 2022–(BUSINESS WIRE)–Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company“) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics as supported by clinical research, announces that its wholly owned subsidiary KGK Sciences Inc. (“KGK”) has opened their new Clinical Research Center in London, Ontario, with the aim to accelerate their clients’ research and drug development needs in the nutraceutical, cannabinoid, hemp and psychedelic space.

KGK will host a grand opening ceremony on September 29, 2022 to officially open the new, state-of-the-art clinical research facility and celebrate being a leading contract research organization for over 25 years. The Company’s clinical research center empowers KGK to provide high-quality clinical research trials and expert regulatory support for clients in the nutraceutical, cannabis, hemp and psychedelic industries.

As a premium full-service contract research organization, KGK is dedicated to providing clinical trial research that meets the highest quality standards. Led by a team of scientific research and regulatory experts, KGK combines cutting-edge clinical science with industry expertise to design clinical trial and claim substantiation strategies customized to meet the needs of our clients. Having over 150 publications, the company is continuously pushing study designs and measurement tools forward in the industry and were most recently published in Frontiers Journal speaking about the assessment and re-evaluation of clinical trial design. The full article can be found here: Breaking new frontiers: Assessment and re-evaluation of clinical trial design for nutraceuticals.

“Our new research center, located in the heart of London, Ontario will draw upon the strength and heritage of applied research and innovation and will be an ongoing opportunity for ground-breaking research in the fields of nutraceuticals, cannabinoids, hemp and psychedelics with global partners, clients and academics, striving for excellence as we have done over the past 25 years,” said Najla Guthrie, CEO of Wellbeing & KGK. “Our goal is to strengthen the fundamental research needed for global innovation and enable the creation of next-generation nutraceuticals and pharmaceuticals.”

Media interested in attending the opening should contact Natalie Dolphin (email: [email protected]; phone: 416-706-6364) by 12 p.m. ET on Thursday, September 29, 2022.

ABOUT KGK SCIENCE

Subsidiary of Wellbeing Digital Sciences, KGK is a leading North American contract research organization based in London, Ontario that primarily provides high-quality clinical research trials with a focus on nutraceutical and emerging health care products. Founded in 1997, the business has successfully helped hundreds of companies with custom designed clinical trials and claim substantiation strategies to move products into global markets. KGK’s other existing service lines include expert regulatory support and compliance solutions, participant recruitment, research support services and consulting services. Furthermore, the company has produced over 150 publications, executed over 400 clinical trials across more than 40 indications, amassed 25,000 participants in its database and collected 10 million data points. For additional information, please visit kgkscience.com.

ABOUT WELLBEING DIGITAL SCIENCES

Wellbeing Digital Sciences Inc. is an evidence-based mental healthcare company focused on the development and implementation of innovative clinical treatment solutions, including psychedelic medicine and digital therapeutics, as supported by clinical research. Its mission is supported by a network of North American clinics that provide forward-thinking therapies and other types of treatment to patients as well as through a contract research organization that offers clinical trials services to clients pursuing drug development. For additional information, please visit wellbeingdigital.co.

On behalf of:
Najla Guthrie
Chief Executive Officer
WELLBEING DIGITAL SCIENCES

Notice Regarding Forward-Looking Information:

This news release contains forward-looking statements including but not limited to statements regarding the Company’s business, assets or investments, as well other statements that are not historical facts. Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties, both general and specific, that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. These assumptions, risks and uncertainties include, among other things, the state of the economy in general and capital markets in particular, investor interest in the business and prospects of the Company.

The forward-looking statements contained in this news release are made as of the date of this news release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities law. Additionally, the Company undertakes no obligation to comment on the expectations of, or statements made, by third parties in respect of the matters discussed above.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220926005255/en/

Contacts

For further information, please contact:
Natalie Dolphin
VP of Marketing & Investment Relations
Email: [email protected]
Twitter: @Wellbeing_IR

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Contrary to popular belief, hemp and marijuana are not two different species of plants. The only actual difference between hemp and marijuana is their THC content. According to the Agricultural Act of 2018, hemp contains 0.3% or less THC than traditional marijuana (cannabis that can get you high). 

Hemp is a versatile plant that manufacturers use to create several products, including paper, clothing, and building materials. Keep reading to learn more about the many uses of this billion-dollar crop. 

Hemp Paper 

Not all paper is made from trees. In fact, hemp paper dates back to the Western Han Dynasty (202 B.C.–9 A.D). According to the American Forest & Paper Association, Chinese court official Ts’ai Lun invented paper using a mixture of mulberry bark, hemp, and water. Lun mashed these ingredients into a pulp, pressed out the liquid, and then hung the remaining mat to dry in the sun. The end result? Paper. 

Lun’s invention didn’t hit the Middle East until 300 years later. It took another 500 years for Europe to catch up. Once word spread to Europe, paper became a popular product. People used it to print books, bibles, and legal documents. 

By 1690, the U.S. had built its first paper mill in Pennsylvania. In the beginning, the U.S. paper mills used Lun’s method. But, as the demand grew, the technique and materials changed. Thanks to the MarijuanaTax Act of 1937, the mills switched from hemp to wood, which was cheaper and legal.

Hemp Foods and Beverages 

Hemp seeds make for a tasty and nutritious topper on yogurt, salads, oatmeal, rice, and veggies. They’re also packed with vitamins (vitamins B and E), minerals (sodium, iron, calcium, sulfur, and potassium, to name a few), and fatty acids (Omega-3 and Omega-6). What’s more? Hemp seeds may produce anti-inflammatory effects. 

Other hemp-based foods include: 

• Hemp seed butter (an alternative for those with a nut allergy).
• Hemp flour (gluten-free and delicious).
• Hemp honey (ideal for sweetening coffee, tea, baked goods, etc.).
• Hemp milk (a non-dairy milk alternative).
• Hemp protein powder (vegan and nutritious).

Hemp can be made into just about anything, including vodka and chewing gum. 

Hemp Building Materials 

Hemp lumber is an eco-friendly alternative to traditional lumber. It has a harvest time of four months (most trees used for lumber can take anywhere between 20 to 80 years). It’s also durable, and according to HempBuild Magazine, it’s 20% harder than oak wood. 

HempWood (owned by Fibonacci LLC, and founded by Greg Wilson) launched a new, sustainable wood alternative in 2019. According to the company’s website, HempWood can be used for flooring, furniture, or other construction materials. Plus, when it comes to price, HempWood is much more affordable than most domestic hardwoods. 

HempWood isn’t the only hemp-based building material out there. Hempcrete (that’s right, a hemp-based concrete alternative) is another versatile construction material. It’s made from hemp hurd (a part of the plant that was previously considered “waste”), lime, and other natural ingredients. Hempcrete is plant-based, energy-efficient, and 100% recyclable.  

According to the Hemp Foundation, the hemp plant has more than 50,000 known uses, from paper to medication. And thanks to the Hemp Farming Act of 2018, American farmers are allowed to grow hemp as a rotational crop. Even so, there are restrictions in place. But, if we keep fighting, hemp may be the answer to a greener tomorrow.

Company Adds New Delta-8 Tincture to Product Line

Orlando, FL , Sept. 22, 2022 (GLOBE NEWSWIRE) — Branded Legacy, Inc. (OTCQB: BLEG), a holding company focused on the commercial development of cannabinoid-infused products from CBD topicals and tinctures to edibles is pleased to announce it has partnered with Apple Rush Company, Inc., (OTC Pink: APRU), to make its Delta 8 tinctures for Spikes CBDX.

Apple Rush Company, Inc., a Texas corporation, is a company that engages in the business of developing, marketing, distributing, and selling products that promote a healthy lifestyle. Its primary focus is the food, beverage, snacks, anhydrous Hemp oil marketplace, kratom, kava, and other active ingredients. It is headquartered in Orlando, Florida.

Tony Torgerud, CEO of Apple Rush, stated “We are excited to partner with Branded Legacy on this product line. APRU has developed its own technologies in water solubility and have produced 100’s of thousand tinctures, drinks, chews, and other products.  We are excited to bring additional products to Branded Legacy and look forward to a long mutually beneficial relationship.”

Brandon Spikes, chairman of Branded Legacy, Inc., stated, “We are pleased to be working with Tony and Apple Rush Company. We had an opportunity to tour their facility in Titusville which was the deciding factor in doing business together. We look forward to building a long-lasting relationship and potentially working together on other projects as well.”

About Spikes CBDX: Spikes CBDX is a line of CBD products designed to assist athletes perform better, recover faster, and avoid injuries. The Company believes that post workout recovery, with Spikes CBDX products, can lower inflammation, aid in making your body stronger, and help recover from injuries naturally. The CBD line also targets individuals who are looking for pain relief, better sleep, faster recovery and lowering inflammation. Spikes CBDX provides tinctures, lotions, moisturizer, and cryo-gel roll-ons. To view all the Spikes CBDX products please visit: spikescbdx.com.

About Elev8 Hemp: Elev8 Hemp’s mission is simple: craft the highest-quality, organic hemp products for consumers in search of a healthier, happier lifestyle. Everyone needs to get the proper amount of healthy proteins to keep them feeling better and more energetic. We source only the best organic hemp protein powders—naturally full of powerhouse amino acids and Omegas-3, 6, and 9—so we can infuse your daily coffee and tea with an abundance of minerals, vitamins, antioxidants, and fiber. www.elev8hemp.com

About Versatile Industries: Versatile Industries, LLC is an acquisition company used to incubate companies to eventually spin off into their own public vehicles. Currently owns patent for a sports training assembly called The Quickness, a solar and water treatment company Magic 1 Promotions, LLC and Astound NMN. By supplementing NMN it helps maintain NAD+ levels, ultimately slowing the effects of aging. www.astoundnmn.com

Safe Harbor Statement:
The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by the use of the words “may,” “will,” “should,” “plans,” “expects,” “anticipates,” “continue,” “estimate,” “project,” “intend,” and similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, and various other factors beyond the Company’s control.

www.brandedlegacy.com
(407) 337-0642
[email protected]

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

• Announces $35 Million Above Market Financing
• Bolsters Company’s Position with Ongoing Strategic Discussions

BUFFALO, N.Y., July 21, 2022 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, announced that it has entered into definitive agreements with several institutional investors for the purchase and sale of 17,073,175 shares of its common stock at a purchase price of $2.05 per share in a registered direct offering priced above market under Nasdaq rules. The Company also agreed to issue to the investors unregistered warrants to purchase up to 17,073,175 shares of common stock. The warrants have an exercise price of $2.05 per share, are immediately exercisable and will expire five years following the date of issuance. The closing of the offering is expected to occur on or about July 25, 2022, subject to the satisfaction of customary closing conditions.

The Company intends to use proceeds from the capital raise to accelerate and expand the launch of its VLN^® reduced nicotine content cigarettes in additional U.S. markets. 22nd Century’s VLN King and VLN Menthol King cigarettes contain 95% less nicotine than conventional cigarettes and are authorized as FDA Modified Risk Tobacco Products (MRTP) that “Help You Smoke Less.” The Company is also evaluating accretive strategic actions to bring further scale its business.

“The results of our Chicago VLN^® pilot with Circle K have been very positive. We are now testing specific incentive programs including couponing designed to encourage adult smokers to try VLN as a means to help them smoke less,” said John Miller, President of 22nd Century Group’s tobacco products. “Based on the early results of our pilot, in addition to expanding availability with our existing partners, we are now engaged with multiple parties that have approached us seeking to launch our disruptive VLN^® products into additional markets and channels.”

“Only as one example, we are in discussion with a large distribution partner in Colorado with extensive coverage of convenience, supermarket and drug stores throughout the state. This prospective partner is eager to incorporate our VLN^® products into its distribution network. The combination of a favorable MRTP tax policy and proactive partner make this an attractive state for launch even before the pilot is complete.”

Additionally, the Company provided an update on its integration of GVB Biopharma, which the company acquired in May 2022. The integration process is advancing ahead of schedule, with steady market activity across GVB’s growing business lines. Proceeds from this transaction are not intended for the GVB business. “The integration of GVB – which doubled our revenue in a single transaction – continues to advance ahead of plan,” said James A. Mish, Chief Executive Officer. “We now offer the most complete hemp/cannabis solution in the world, from 22nd Century’s core expertise in receptor science and transformative plant genetics to GVB’s leading position in finished ingredients and CDMO formulated products. Customers and new potential customers are taking note, driving real growth in this business as our combined capabilities drive new momentum on several key opportunities, including the ramp up of new revenue opportunities.

The Special Equities Group (SEG), a division of Dawson James Securities, Inc., acted as sole placement agent for the transaction. Roth Capital Partners acted as a financial advisor.

Full terms of the financing agreement can be found in the Company’s Current Report on Form 8-K to be filed with the U.S. Securities and Exchange Commission.

About 22^nd Century Group, Inc.
22^nd Century Group, Inc. (Nasdaq: XXII) is a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. With dozens of patents allowing it to regulate nicotine biosynthesis in the tobacco plant, the Company has developed proprietary reduced nicotine content (RNC) tobacco plants and cigarettes, which have become the cornerstone of the FDA’s Comprehensive Plan to address the widespread death and disease caused by smoking. The Company received the first and only FDA MRTP authorization of a combustible cigarette in December 2021. In tobacco, hemp/cannabis, and hop plants, 22nd Century uses modern plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the life science and consumer products industries by creating new, proprietary plants with optimized alkaloid and flavonoid profiles, as well as improved yields and other valuable agronomic traits.

Learn more at xxiicentury.com, on Twitter, on LinkedIn, and on YouTube.

Cautionary Note Regarding Forward-Looking Statements
Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements. Forward-looking statements typically contain terms such as “anticipate,” “believe,” “consider,” “continue,” “could,” “estimate,” “expect,” “explore,” “foresee,” “goal,” “guidance,” “intend,” “likely,” “may,” “plan,” “potential,” “predict,” “preliminary,” “probable,” “project,” “promising,” “seek,” “should,” “will,” “would,” and similar expressions. Actual results might differ materially from those explicit or implicit in forward-looking statements. Important factors that could cause actual results to differ materially are set forth in “Risk Factors” in the Company’s Annual Report on Form 10-K filed on March 1, 2022. All information provided in this release is as of the date hereof, and the Company assumes no obligation to and does not intend to update these forward-looking statements, except as required by law.

Investor Relations & Media Contact:
Mei Kuo
22nd Century Group, Inc.
Director, Communications & Investor Relations
T: 716-300-1221
[email protected]

Darrow Associates Investor Relations
Matt Kreps
T: 214-597-8200
[email protected]

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Vancouver, British Columbia, June 2, 2022 – Naturally Splendid Enterprises Ltd. (“Naturally Splendid” or “NSE” or the “Company” ) (FRANKFURT:50N) (TSX-V:NSP) (OTC:NSPDF), the Company is pleased to announce another shipping container of Plantein Plant-Based Foods has been ordered and is being shipped to the Company’s facility in Pitt Meadows, British Columbia.

This most recent order addresses the positive response the Company received during the Canadian Health Food Association (CHFA) trade show on April 23 and April 24, and the Grocery & Specialty Food West (GSFW) trade show on April 25 and April 26. This latest shipment left the Ports in Australia on May 31, 2022 and is scheduled to arrive in approximately four (4) weeks.

Naturally Splendid VP of Operations Bryan Carson reports, “The trade shows that we
presented recently at was the first opportunity to sample our plant-based entrees in a trade show environment since the beginning of the pandemic. And as we expected, the response to our plant-based entrees’ taste and consumer experience has been extremely positive. We are now in the process of converting that interest into clients, and this latest shipment from Australia will provide the inventory levels required to serve anticipated demand. We look forward to providing updates as both retail and food service business grows.”

About Naturally Splendid Enterprises Ltd.

Naturally Splendid is a plant-based food manufacturing and technology company that produces and distributes nutritious and delicious plant-based commodity products.

Founded in 2010, the Company operates a Safe Quality Food Level 2 certified food manufacturing facility located just outside Vancouver, BC in Canada, focusing on producing an extensive range of plant-based entrees.

Naturally Splendid has an exclusive 10-year manufacturing and distribution agreement for Canada with a division of Australia’s largest plant-based food manufacturer, Flexitarian
Foods Pty. Ltd.

In addition to producing the Company’s own branded products, Naturally Splendid provides contract manufacturing services and private labeling for a variety of nutritional plant-based food products destined for multiple distribution channels.

The Company has established healthy, functional foods under brands such as Natera Sport, Natera Hemp Foods, CHII, Elevate Me and Woods Wild Bar. The Company launched Natera Plant Based Foods, a line of delicious plant-based meat alternatives for the rapidly growing plant-based market segment.

Naturally Splendid maintains a relationship Plasm Pharmaceutical, a company that has been approved for conducting a phase 2 clinical trial approved by Health Canada for the treatment of COVID-19.   NSE has also developed proprietary technologies for the extraction of healthy omega 3 and 6 oils, as well as a protein concentrate from hemp.

On Behalf of the Board of Directors

Mr. J. Craig Goodwin

President, Director

Contact Information

Naturally Splendid Enterprises Ltd.

(NSP – TSX Venture; NSPDF – OTCQB; 50N Frankfurt)

#108-19100 Airport Way

Pitt Meadows, BC, V3Y 0E2

Office: (604) 570-0902

Fax: (604) 465-1128

Forward-Looking Statements

Information set forth in this news release
contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Naturally Splendid cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Naturally Splendid’s control including, Naturally Splendid’s ability to compete with large food and beverage companies; sales of any potential products developed will be profitable; sales of shelled hemp seed will continue at existing rates or increase; customers will complete on sales contracts; and the risk that any of the potential applications may not receive all required regulatory or legal approval. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations
expressed or implied in the forward-looking information. Except as required under applicable securities legislation, Naturally Splendid undertakes no obligation to publicly update or revise forward-looking information.

NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Company recorded revenues of approximately $400,000 in the month of March

Melbourne, FL, April 04, 2022 (GLOBE NEWSWIRE) — Kona Gold Beverage, Inc. (OTC Pink: KGKG), a holding company focused on product development in the better-for-you and hemp and CBD functional beverage sector, is pleased to announce the Company had revenues of over one million dollars in the first quarter of 2022. This marks the Company’s first quarter of one million dollars or more, which is a huge milestone and testament to the continued growth it’s experiencing. Kona Gold Beverages two subsidiaries, Kona Gold LLC and Gold Leaf Distribution LLC’s combined revenue broke the one-million-dollar mark in Q1.

Gold Leaf Distribution, the Company’s distribution subsidiary, continues to have record month-over-month revenue and March was no exception. March revenue projections for Gold Leaf were $260,000 and the Company did approximately $310,000 in revenue, exceeding projections by approximately 19%.

“Q1 marks a huge milestone for Kona Gold Beverage with over one million dollars in sales and I couldn’t be prouder of our team,” stated Robert Clark, CEO of Kona Gold Beverage, Inc. “We did miss our Q1 projections by roughly $60,000, but the sales that were anticipated to post in March, will be posting in April, so we are right on track and where we want to be. In April, we anticipate a big uptick in revenue from our Kona Gold subsidiary’s Ooh La Lemin product lines. We have several current and new distribution partners that will be placing orders in preparation for Walmart roll outs and to begin selling into other retail chains.”

Clark continued, “Our distribution subsidiary, Gold Leaf, continues to beat our estimates and expectations, with over $300,000 in sales in the month of March. Gold Leaf is nearing profitability as its new distribution center in Conway South Carolina quickly ramps up. Gold Leaf has also begun distributing our new Sparkling Ooh La Lemin Lemonades to Walmart retail locations in South Carolina and anticipates an upswing in revenue as Gold Leaf continues to distribute to additional locations.”

Kona Gold announced last month its popular Ooh La Lemin Lemonades will be sold in Walmart brick and mortar stores. The Company’s 16 oz Ooh La Lemin Lemonades, available in 4 flavors, will be included in modular sets in all stores with 12 ft or wider coolers in select states starting in June of 2022. The Company will announce which states at a later date as it gets closer to launch. The 4 flavors of Ooh La Lemin will be in Walmart’s system nationwide, which will give the Company fire power to secure distribution in states where it’s currently lacking.

This is a huge step forward for Kona Gold Beverage as the Company focuses on taking its brand portfolio nationally. The Company’s Ooh La Lemin Lemonades are currently sold in popular chains such as Wawa, Plaid Pantry, Piggly Wiggly, Coborn’s, Hyvee, and others. The Company is currently in talks with several other national retailors to carry its Ooh La Lemin Lemonades, and will update shareholders as those come to fruition.

For more information regarding Kona Gold Beverage, please visit:
https://konagoldbeverage.com/

About Kona Gold Beverage, Inc.

Kona Gold Beverage, Inc., a Delaware corporation, has created wholly-owned subsidiaries, Kona Gold LLC, HighDrate, LLC, and Gold Leaf Distribution, LLC. Kona Gold, LLC has developed a premium Hemp-Infused Energy Drink line; please visit its website at www.konagoldhemp.com. HighDrate, LLC has developed the beverage industry’s first CBD-Infused Energy Water, available in 6 delicious flavors; please visit its website at www.highdrateme.com. Gold Leaf Distribution, LLC was created to fill the Company’s distribution needs in markets that it wants to enter quickly; please visit its website at www.goldleafdist.com. Kona Gold Beverage, Inc. recently rebranded its Lemin Lemonade to Ooh La Lemin Lemonade; please visit its website at www.oohlalemin.com. Kona Gold and its family of companies are located on the east coast of Florida in Melbourne and in Greer and Conway South Carolina.

Safe Harbor Statement:

The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words “may,” “will,” “should,” “plans,” “expects,” “anticipates,” “continue,” “estimate,” “project,” “intend,” and similar expressions. The Company may also make written or oral forward-looking statements in its filings with the U.S. Securities and Exchange Commission, in press releases and other written materials, and in oral statements made by its officers, directors or employees to third parties. There can be no assurance that such statements will prove to be accurate. The Company cautions that these forward-looking statements are further qualified by other factors including, but not limited to, those set forth in the Company’s Registration Statement on Form S-1. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, and various other factors beyond the Company’s control. The Company does not undertake any obligation to update publicly or to revise any statements in this release, whether as a result of new information, future events, or otherwise.

Investor Relations Contact:
Robert Clark
844-714-2224
[email protected]

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.